Deaths and disability from natalizumab are no longer tolerable: No – (they can be avoided).
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1070, doi. 10.1177/1352458512451946
- By:
- Publication type:
- Article
Works matching IS 13524585 AND DT 2012 AND VI 18 AND IP 8
Results: 21
1
2
Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1116, doi. 10.1177/1352458511434066
- By:
- Publication type:
- Article
3
Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1170, doi. 10.1177/1352458511433918
- By:
- Publication type:
- Article
4
Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1092, doi. 10.1177/1352458511433306
- By:
- Publication type:
- Article
5
Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNβ-1a in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1125, doi. 10.1177/1352458511433304
- By:
- Publication type:
- Article
6
The role of mitochondria in axonal degeneration and tissue repair in MS.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1058, doi. 10.1177/1352458512452924
- By:
- Publication type:
- Article
7
Deaths and disability from natalizumab are no longer tolerable: Commentary.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
8
Deaths and disability from natalizumab are no longer tolerable: Yes.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1068, doi. 10.1177/1352458512451945
- By:
- Publication type:
- Article
9
Natalizumab discontinuation after PML risk stratification: outcome from a shared and informed decision.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
10
Revisiting The Multiple Sclerosis Functional Composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
11
Are Mycobacterium avium subsp. paratuberculosis and Epstein–Barr virus triggers of multiple sclerosis in Sardinia?
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1181, doi. 10.1177/1352458511433430
- By:
- Publication type:
- Article
12
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
13
Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1144, doi. 10.1177/1352458511434607
- By:
- Publication type:
- Article
14
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1188, doi. 10.1177/1352458511434067
- By:
- Publication type:
- Article
15
National estimate of multiple sclerosis incidence in France (2001–2007).
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1108, doi. 10.1177/1352458511433305
- By:
- Publication type:
- Article
16
Epstein–Barr virus neutralizing antibody levels and risk of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1185, doi. 10.1177/1352458511433920
- By:
- Publication type:
- Article
17
Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1152, doi. 10.1177/1352458511433919
- By:
- Publication type:
- Article
18
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1081, doi. 10.1177/1352458511433303
- By:
- Publication type:
- Article
19
A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1099, doi. 10.1177/1352458511433062
- By:
- Publication type:
- Article
20
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1159, doi. 10.1177/1352458511432328
- By:
- Publication type:
- Article
21
Neuromyelitis optica spectrum disorders in patients with myasthenia gravis: ten new aquaporin-4 antibody positive cases and a review of the literature.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 8, p. 1135, doi. 10.1177/1352458511431728
- By:
- Publication type:
- Article